Conference abstractPublished 16 Oct 2017
A snapshot on the molecular epidemiology of hepatitis B and C in Morocco
Pasteur Institute of Morocco, Morocco
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Viral hepatitis is a serious public health problem affecting billions of people globally. Together, hepatitis B virus (HBV) and hepatitis C (HCV) are the leading cause of liver cancer in the world. The objective of this exhaustive study was to draw an epidemiological and molecular portrait of HBV and HCV infections in Morocco. A seroprevalence survey was conducted in the general population and blood donors. We confirmed the intermediate endemicity for HCV infection and noted a downward trend in the incidence of HBV, which might reclassify Morocco in low HBV endemicity area. The HCV infection was primarily associated with nosocomial exposures. Additionally, sexual risk behaviors were associated with higher prevalence of HBV among adults. The study of the HBV genetic diversity showed a predominance of genotype D and apparition for the first time of genotype E and mixed infections A/D and D/F. We also reported that precore variants could be found in more than three quarters of Moroccan patients with HBV infection. Their prevalence was related to HBV genotypes. In addition, we have characterized the first cases of antiviral resistance in patients under treatment and no mutation was detected in naive subjects. Concerning hepatitis C, its diversity was analyzed over a period of fifteen years. Five genotypes and eight subtypes have been identified. We have shown a predominance of genotype 1 and a global codominance of subtypes 1b and 2a/2c. Drug addiction was the primary mode of spread of 3a subtype. Subtype 1b was prevalent in patients with cirrhosis confirming thus, its association with severe liver disease. Pilgrims follow comparably the national trend with an increased prevalence in older people and the presence of genotypes 1, 2 and 4. Among multi-transfused patients, despite the unique presence of genotype 1, the contribution of transfusion in HCV transmission has not been demonstrated.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Antivirals & Antiretrovirals
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Warda Baha”
- BylineArticles whose byline prints “Abdelouaheb Benani”
